Explore the science behind FDA drug approvals and discover why even promising “breakthrough” drugs can fail. From clinical trials and safety checks to study design and risk-benefit analysis, here’s what
Explore the science behind FDA drug approvals and discover why even promising “breakthrough” drugs can fail. From clinical trials and safety checks to study design and risk-benefit analysis, here’s what
Most medicines and medical devices, as you may already know, go through a long journey of carefully controlled clinical trials before reaching the market. These trials are absolutely essential. However,
FDA just launched TEMPO, a digital health strategy that can come as a boon for people with chronic ailments.
Durvalumab, a monoclonal antibody gets a nod from the FDA to be used in resectable stomach cancers. Read more for full story.